Skip to main content
. 2017 Nov 6;9(12):1007–1012. doi: 10.14740/jocmr3219w

Table 3. Changes in eGFR and UACR by Urate-Lowering Agents.

0 week Urate < 6.0 mg/dL 52 weeks
eGFR (mL/min/1.73 m2)
  Allopurinol 76.0 ± 6.8 80.0 ± 5.5 82.4 ± 9.8
  Benzbromarone 74.7 ± 6.9 88.1 ± 10.0* 85.0 ± 9.0*
  Febuxostat 60.3 ± 3.6 64.8 ± 3.9* 63.1 ± 3.9
UACR (mg/g Cr)
  Allopurinol 22.9 ± 9.3 13.5 ± 6.0
  Benzbromarone 9.7 ± 1.9 15.2 ± 6.4
  Febuxostat 119.3 ± 44.7 121.3 ± 50.8

*P < 0.05 vs. 0 week.